{"disease":{"id":"nonsense-mutation","name":"nonsense mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03309605","title":"Phase 1 Study of ELX-02 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Eloxx Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03292302","title":"Phase 1 Study of ELX-02 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Eloxx Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04069260","title":"A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Eloxx Pharmaceuticals, Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}